comparemela.com

Latest Breaking News On - Wafra inc - Page 1 : comparemela.com

Evoke Wealth LLC Makes New $1.36 Million Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Evoke Wealth LLC purchased a new position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 36,657 shares of the biopharmaceutical company’s stock, valued at approximately $1,355,000. A number of other […]

Belgium
United-states
Boston
Massachusetts
Switzerland
Japan
Michaelj-labarre
Norges-bank
Exchange-commission
Securities-exchange-commission
International-assets-investment-management

TD Asset Management Inc Increases Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

TD Asset Management Inc Increases Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Japan
Belgium
Switzerland
Michaelj-labarre
Harvey-capital-management-inc
Hsbc-holdings
Wafra-inc
Exchange-commission

Wafra wins Euromoney award

Wafra wins Euromoney award
royalgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from royalgazette.com Daily Mail and Mail on Sunday newspapers.

Dubai
Dubayy
United-arab-emirates
Bermuda
Ron-solenske
Wafra-inc
Islamic-fund
New-york-headquartered
Best-islamic-fund-manager
Euromoney-islamic-finance-awards
Elias-scheker-da-silva
Scheker-da-silva

Halozyme Therapeutics' (HALO) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $50.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts also recently issued research reports about the stock. TD Cowen began coverage on shares of […]

Boston
Massachusetts
United-states
Belgium
Japan
Switzerland
Michaelj-labarre
Halozyme-therapeutics-company-profile
Wafra-inc
Hsbc-holdings
Nasdaq

HC Wainwright Reaffirms Buy Rating for Halozyme Therapeutics (NASDAQ:HALO)

HC Wainwright restated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a research note released on Wednesday morning, Benzinga reports. They currently have a $50.00 target price on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. JMP Securities cut their target price on shares of […]

Boston
Massachusetts
United-states
Belgium
Switzerland
Japan
Michaelj-labarre
Hsbc-holdings
Wafra-inc
International-assets-investment-management
Securities-exchange-commission

vimarsana © 2020. All Rights Reserved.